Advertisement

Picture [iito] Back into Ad 650x80px
Organisation › Details

Allecra Therapeutics GmbH

Allecra is a biopharmaceutical company established in 2013 in the European BioValley Life Sciences cluster located in the Upper Rhine valley around the Basel region of northwest Switzerland including southwest Germany and the Alsace Region of France. Allecra is focused on the development of novel treatments to combat multi drugresistant Gram-negative bacterial infections. Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms, thereby saving lives of patients whose infections may otherwise be inadequately treated. Allecra is supported by existing investors Forbion, Delos Capital, EdRIP, Xeraya Capital, EMBL Ventures, BioMed Partners and Nicholas Benedict. Allecra’s wholly-owned French subsidiary is a beneficiary of financial support from the French public bank Bpifrance and from the Région Alsace. *

 

Period Start 2013-04-01 established
  Group Allecra Therapeutics (Group)
Products Industry AAI101 (Allecra Therapeutics)
  Industry 2 AAI202 (Allecra Therapeutics)
Persons Person Benedict, Nicholas (Allecra Therapeutics 201304 CEO + Co-Founder)
  Person 2 Reithinger, Holger (Forbion 201004– Managing Director Forbion Capital Partners Munich before GLSV Munich + 3i Germany)
     
Region Region Weil am Rhein
  Country Germany
  Street 9 Im Kränzliacker
  City 79576 Weil am Rhein
  Tel +41-79-592-2005
    Address record changed: 2020-05-17
     
Basic data Employees n. a.
     
    * Document for �About Section�: Allecra Therapeutics GmbH. (3/26/18). "Press Release: Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of Its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)". Lö
     
   
Record changed: 2020-05-17

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Allecra Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] No Content Marketing 650x80px




» top